Heart failure is a risk factor for Alzheimer's disease and cerebrovascular disease. In the absence of heart failure, it was hypothesized that left ventricular ejection fraction (LVEF), an indicator of cardiac dysfunction, would be associated with preclinical brain magnetic resonance imaging (MRI) and neuropsychological markers of ischemia and Alzheimer disease in the community. Brain MRI, cardiac MRI, neuropsychological, and laboratory data were collected from 1,114 Framingham Heart Study Offspring Cohort participants free from clinical stroke or dementia (aged 40 to 89 years, mean age 67 ؎ 9 years, 54% women). Neuropsychological and neuroimaging markers of brain aging were related to cardiac MRI-assessed LVEF. In multivariable In patients with severe cardiomyopathies, left ventricular ejection fraction (LVEF) is related to abnormal brain aging, including cognitive impairment, 1 structural neuroanatomic abnormalities, 2 and increased risk for Alzheimer's disease (AD).
In patients with severe cardiomyopathies, left ventricular ejection fraction (LVEF) is related to abnormal brain aging, including cognitive impairment, 1 structural neuroanatomic abnormalities, 2 and increased risk for Alzheimer's disease (AD). 3 Cognitive impairment diminishes 4 and cerebral blood flow increases by Ͼ50% after heart transplantation, 5 purportedly because of improvement in cardiac function. Therefore, a reduced LVEF may influence cerebral perfusion homeostasis and contribute to clinical brain injury. In the absence of end-stage heart disease, less is known about how LVEF affects or accelerates abnormal brain aging. The aim of this cross-sectional investigation was to better understand relations between LVEF and abnormal brain aging by extending previous work to a large, epidemiologic cohort, assessing LVEF using sensitive cardiac magnetic resonance imaging (MRI), and simultaneously considering shared vascular risks for brain and myocardial injury. On the basis of previous work, we hypothesized that a lower LVEF would be associated with cognitive and neuroimaging markers of preclinical AD 6, 7 (learning and memory, brain volume, temporal horn volume, and hippocampal volume) and cerebrovascular changes 8, 9 (executive functioning and white matter hyperintensities [WMH] ) in a community-based cohort of adults free of clinical dementia or stroke.
Methods
The Framingham Offspring Study design and selection criteria have been described elsewhere. 10 From 1971 to 1975, 5,124 participants were recruited and have been examined every 4 to 8 years since. Details on the derivation of the current sample are provided in Figure 1 . The protocol was approved by the local institutional review board. Participants provided written informed consent before assessments.
Participants completed the following cognitive protocol, which was selected a priori to represent different cognitive systems: (1) For brain imaging acquisition, images were obtained using a Siemens 1-T magnetic resonance machine (Siemens Medical Systems, Erlangen, Germany) using a T2-weighted double spin-echo coronal imaging sequence. Digital information was postprocessed by a central laboratory blinded to demographic and clinical information. A custom-written, semiautomatic segmentation protocol was used to quantify total cranial, 11 total brain, 12 frontal lobar, 13 temporal horn, 13 and hippocampal 14 volumes and WMH segmentation. 12 Interrater reliabilities for these methods have been published elsewhere. 11, 13, 15, 16 For this study, intra-and interrater reliabilities were consistently Ͼ0.90. Hippocampal data were available for a subset of participants (n ϭ 423). For cardiac MRI acquisition, images were obtained with participants in the supine position using a Philips 1.5-T MR system (Philips Medical Systems, Andover, Massachusetts) with a 5-element (3 anterior, 2 posterior) surface coil. Images were acquired at end-tidal breath hold and analyzed by a single, experienced, blinded reviewer using a commercial workstation (EasyVision 4.0; Philips Medical Systems). End-systolic phase was determined as the minimal cross-sectional area of a midventricular slice. The time delay from the QRS complex (phase) was analyzed for each contiguous slice, and endocardial borders were segmented. Enddiastolic volume and end-systolic volume were computed by summation of disks (i.e., modified Simpson's rule) to derive the LVEF ([end-diastolic volume Ϫ end-systolic volume]/enddiastolic volume). Intra-and interobserver coefficients of variation for these methods have been published elsewhere. 17 For this study, interrater reliabilities were consistently Ͼ0.92.
18
Total brain, frontal lobe, temporal horn, and hippocampal volumes and WMH were expressed as percentages of total cranial volume. WMH, Trail Making Test Part B Ϫ Part A, and Hooper Visual Organization Test were natural log-transformed to normalize distributions. As previously described, 18 neuropsychological scores were adjusted for age and education, separately by sex, to enable comparison across measures. Resulting values were standardized, separately by gender, to a mean of 0 and a standard deviation of 1 (i.e., values were transformed to represent standard deviation units from the mean).
We used regression to assess linear relations between the LVEF and each brain aging variable. Next, we compared brain aging variables among participants classified by LVEF quintile and noted U-shaped associations. We therefore compared the lower (quintile 1) and upper (quintile 5) quintiles to the referent (quintiles 2 to 4) for each brain aging variable. On the basis of previous work, 18 we adjusted for covariates defined at the seventh examination cycle, including age, sex, systolic blood pressure, smoking status, diabetes mellitus (i.e., history of fasting blood glucose Ն126 mg/dl or use of oral hypoglycemic or insulin), hypertension treatment, atrial fibrillation, and prevalent cardiovascular disease (CVD), including coronary heart disease, heart failure, and intermittent claudication. 19 Secondary analyses were performed (1) excluding prevalent CVD (n ϭ 77); (2) using the categorical LVEF variable (i.e., quintile 1, quintile 5, and referent quintiles 2 to 4) assessing effect modification by sex, age (Ͻ60 vs Ն60 years), and APOE-4 status 20 (4Ϫ vs 4ϩ) and stratifying analyses by subgroups as indicated. Significance was set at p Ͻ0.05 for all models. Data were analyzed using SAS version 9.1 (SAS Institute Inc., Cary, North Carolina).
Results
Clinical characteristics are listed in Table 1 . Cardiac MRI, brain MRI, and neuropsychological descriptive variables are listed in Table 2 . As a continuous variable, the LVEF was unrelated to any brain MRI or neuropsychological variable (Table 3 ). Findings were not altered when participants with CVD were excluded (Table 4) .
When LVEF quintiles were compared to assess associations with brain aging variables, participants in quintile 1 did not differ from the referent group (quintiles 2 to 4) for any of the brain MRI variables (Table 3) . However, participants in quintile 1 differed from the referent group for Visual Reproduction Delayed Recall (p Ͻ0.001) and Hooper Visual Organization Test (p Ͻ0.001) ( Table 3 ), such that lower LVEF values were associated with poorer mean cognitive performance. When participants with prevalent CVD were excluded, findings were similar (Table 4) . Compared to the referent, participants in quintile 5 performed more poorly on Logical Memory Delayed Recall Table 3 ). The nonlinear association between LVEF quintiles and Visual Reproduction Delayed Recall is illustrated in Figure 2 . When analyses were repeated excluding participants with prevalent CVD, findings were similar (Table 4) . To determine if a clinically low LVEF accounted for the association between quintile 1 and cognition, participants in quintile 1 were dichotomized into groups with LVEF Ͻ55% (n ϭ 41) and LVEF Ն55% (n ϭ 184). Compared to the referent (quintiles 2 to 4), the lowest (Ͻ55%) LVEF subgroup had worse Visual Reproduction Delayed Recall (␤ ϭ Ϫ0.42, p ϭ 0.01) but not Hooper Visual Organization Test (␤ ϭ Ϫ0.16, p ϭ 0.34) performance. However, the low normal (Ն55%) LVEF subgroup had worse Visual Reproduction Delayed Recall (␤ ϭ Ϫ0.24, p ϭ 0.004) and To better understand the observed U-shaped association (and the relation between quintile 5 LVEF and worse cognitive performances), the multivariate-adjusted 3-category models were repeated, excluding participants with prevalent CVD and adding heart rate, C-reactive protein, body mass index, cardiac index, 18 and height-indexed left ventricular mass as covariates, which resulted in strengthened statistical significance of the primary findings (see Supplemental Table 1). The frequencies of mitral and aortic regurgitation were not disproportionately higher or lower in the highest LVEF quintile.
There was an interaction between sex and the categorical LVEF variable (quintile 1, quintiles 2 to 4, and quintile 5) in their association with Boston Naming Test-30 Item (p ϭ 0.03), but there was no effect in stratified analyses (all p values Ͼ0.09). No interactions were observed between LVEF category and age or APOE-4 status in relation to the brain aging variables.
Discussion
Our epidemiologic findings suggest a U-shaped association, rather than a linear relation, between LVEF and markers of abnormal brain aging. Participants in the lowest and highest LVEF quintiles had cross-sectional evidence of abnormal cognitive changes compared to the middle referent group. The observation that a lower LVEF is associated with abnormal brain changes extends previous research examining patients with severe cardiomyopathies, which reported that a reduced LVEF was associated with memory, 4,21 reasoning, 22 and sequencing impairments. 22 In the absence of clinical heart failure and prevalent CVD, our findings suggest that lower LVEFs are also related to abnormal brain aging. It is noteworthy that the lowest quintile of LVEF (which had significant associations with visuospatial memory and object recognition) included mostly participants with clinically normal values (i.e., 55% to 62%). The observation that even low normal values of systolic function can be associated with cross-sectional markers of abnormal brain aging is consistent with our recent work reporting that low normal values of cardiac index are associated with smaller brain volumes. 18 The mechanism underlying associations between a lower LVEF at rest and abnormal brain aging is unknown. Despite auto-regulatory mechanisms, cerebral blood flow values are low in heart transplantation candidates but return to normal after heart transplantation. 23 Disruption of cerebral perfusion may contribute to clinical or subclinical brain injury by propagating or exacerbating cerebrovascular disease, including alterations in microvessel structure, expression of vascular cell receptors, microvessel permeability changes, and vascular remodeling. 24, 25 Chronic cerebral hypoperfusion in animals leads to the development 8, 9 and progression 8 of white matter changes. Another pathologic mechanism could be AD, as rats develop AD-related neuropathology, including diffuse ␤-amyloid peptide and amyloid precursor protein expression in the hippocampus, entorhinal cortex, and neocortex, after the acute cessation of blood flow. 26 Chronic cerebral hypoperfusion places the brain at risk for amyloid deposition, resulting in neuronal death in transgenic AD mice. 27 More research is needed to understand the mechanism accounting for the associations reported here.
An unexpected observation from the present study was that participants in the highest (top) LVEF quintile also had poorer cognitive performance in verbal and visuospatial memory, executive functioning, and visuoperceptual abilities compared to the referent. These findings persisted despite adjusting for multiple covariates, excluding participants with prevalent CVD, and post hoc consideration of additional possible confounders (e.g., enhanced inflammatory process, greater body mass index, lower cardiac index, or left ventricular hypertrophy). The mechanism underlying this observation is unknown. Whereas healthy LVEFs may be good for brain health, very high LVEFs may correspond to subtle cognitive impairment. Alternatively, our observation may reflect an epiphenomenon or another pathologic process that was not analytically considered in our models, such as anemia or thyroid disease. 28 The observed U-shaped association between the LVEF and cognitive aging requires further study, including the clinical significance of cognitive impairment, such as early functional loss. 29 Our study had several strengths, including the large community-based cohort free of clinical dementia and stroke, comprehensive ascertainment of possible confounders, innovative cardiac imaging, rigorous quality control procedures, and core reading laboratory for processing measurements, blinded to the participants' cognitive status. However, there were methodologic limitations. The cohort was predominantly white, of European descent, and middle aged to elderly, so the generalizability to other races, ethnicities, and age groups is unknown. The ambulatory nature of the cohort, the exclusion of participants with clinical stroke or dementia, and the inclusion of subjects willing to undergo MRI yielded a healthier sample, reducing the likelihood of detecting relations that may be present in patients with more co-morbidities. The smaller data set available for analyses relating LVEF to hippocampal volume may have been insufficiently powered. Analyses were cross sectional and observational; hence, we are unable to establish a causal connection between cardiac function and brain measures. The potential for false-positive findings given the multiple statistical tests is also a concern. By accounting for multiple potential confounders, we may have "overadjusted" our models, as LVEF may predispose to cognitive impairment through intermediate mechanisms, such as hypertension or diabetes. Finally, the cardiac MRI data were acquired on average 2.5 years before the brain MRI and neuropsychological data.
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